The impact of insurance status on progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Castro, Daniela [1 ]
Tripathi, Nishita [2 ]
Sayegh, Nicolas [2 ]
Gebrael, Georges [2 ]
Li, Xiaochen [1 ]
Meza, Luis [1 ]
Zengin, Zeynep [1 ]
Chehrazi-Raffle, Alex [1 ]
Govindarajan, Ameish [1 ]
Dizman, Nazli [1 ,3 ]
Ebrahimi, Hedyeh [1 ]
Chawla, Neal [1 ]
Mercier, Benjamin [1 ]
Hsu, Joann [1 ]
Shi, Jessica [1 ]
Philip, Errol [4 ]
Bergerot, Cristiane [5 ]
Barragan-Carrillo, Regina [1 ,6 ]
Pal, Sumanta [1 ]
机构：
[1] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA
[2] Univ Utah, Huntsman Canc Inst, Div Med Oncol, Salt Lake City, UT USA
[3] Yale Univ, Dept Internal Med, Sch Med, New Haven, CT USA
[4] Univ Calif San Francisco, San Francisco, CA USA
[5] Ctr Canc Brasilia CETTRO, Inst Unity Ensino & Pesquisa, Brasilia, DF, Brazil
[6] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
来源：
ONCOLOGIST | 2023年 / 28卷
关键词：
insurance status; clinical outcomes; disparities; social determinants of health;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
45
引用
收藏
页码：S5 / +
页数：2
相关论文
共 46 条
  • [41] Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma
    Zhou, Ping
    Yu, Yi-Feng
    Lian, Chen-Lu
    Wang, Jun
    Zhuo, Ren-Gong
    Wu, San-Gang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Does an Alternative Sunitinib Dosing Schedule Really Improve Survival Outcomes Over a Conventional Dosing Schedule in Patients with Metastatic Renal Cell Carcinoma? An Updated Systematic Review and Meta-Analysis
    Chung, Doo Yong
    Kang, Dong Hyuk
    Kim, Jong Won
    Kim, Do Kyung
    Lee, Joo Yong
    Hong, Chang Hee
    Cho, Kang Su
    CANCERS, 2019, 11 (12)
  • [43] Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the Lung
    Ramalingam, Sendhilnathan
    Dinan, Michaela A.
    Crawford, Jeffrey
    CLINICAL LUNG CANCER, 2021, 22 (04) : E646 - E653
  • [44] Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis
    Ahmed, Hiba Z.
    Liu, Yuan
    O'Connell, Kelli
    Ahmed, Maaz Z.
    Cassidy, Richard J.
    Gillespie, Theresa W.
    Patel, Pretesh
    Pillai, Rathi N.
    Behera, Madhusmita
    Steuer, Conor E.
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Curran, Walter J.
    Higgins, Kristin A.
    CLINICAL LUNG CANCER, 2017, 18 (06) : 706 - 718
  • [45] Effects of insurance status on long-term survival among non-small cell lung cancer (NSCLC) patients in Beijing, China: A population-based study
    Wang, Zheng
    Yang, Lei
    Liu, Shuo
    Li, Huichao
    Zhang, Xi
    Wang, Ning
    Ji, Jiafu
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (05) : 596 - +
  • [46] The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients
    Jiang, Mei
    Fares, Aline F.
    Shepshelovich, Daniel
    Yang, Ping
    Christiani, David
    Zhang, Jie
    Shiraishi, Kouya
    Ryan, Brid M.
    Chen, Chu
    Schwartz, Ann G.
    Tardon, Adonina
    Shete, Sanjay
    Schabath, Matthew B.
    Teare, M. Dawn
    Le Marchand, Loic
    Zhang, Zuo-Feng
    Field, John K.
    Brenner, Hermann
    Diao, Nancy
    Xie, Juntao
    Kohno, Takashi
    Harris, Curtis C.
    Wenzlaff, Angela S.
    Fernandez-Tardon, Guillermo
    Ye, Yuanqing
    Taylor, Fiona
    Wilkens, Lynne R.
    Davies, Michael
    Liu, Yi
    Barnett, Matt J.
    Goodman, Gary E.
    Morgenstern, Hal
    Holleczek, Bernd
    Thomas, Sera
    Brown, M. Catherine
    Hung, Rayjean J.
    Xu, Wei
    Liu, Geoffrey
    LUNG CANCER, 2021, 152 : 58 - 65
12345